Several oncogenes, including MYC, phosphoinositide-3-kinase (PI3K), KRAS, protein kinase B (AKT), mechanistic target of rapamycin (MTOR), and HIF-1, are implicated in the regulation of cancer metabolic reprogramming [42]. The gene discussed is MYC; the disease is cancer.